# Post Marketing Surveillance Study for ADYNOVATE in South Korea

> **NCT03824522** · — · COMPLETED · sponsor: **Takeda** · enrollment: 341 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** ADYNOVATE

## Key facts

- **NCT ID:** NCT03824522
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-25
- **Primary completion:** 2024-01-05
- **Final completion:** 2024-01-05
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2024-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824522, "Post Marketing Surveillance Study for ADYNOVATE in South Korea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03824522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*